• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC TORIC INTRAOCULAR LENS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Uveitis (2122)
Event Type  Injury  
Event Description
The reporter indicated that bilateral sequential icl surgery was performed and implantable collamer lens that was reflected in this complaint was implanted into the patient's right eye (od).The date of implantation was not provided.Concomitant products used during the procedure were: bss, intracameral vigamox, lidocaine.Examination on (b)(6) 2023 showed presentation of anterior chamber cells and iop of 19mmhg.Postoperative uveitis was reported on (b)(6) 2023.Steroid and antibiotic drops were prescribed.The patient had a pre-existing health history of asthma and covid infection.No loss of bcva was reported.The lens remains implanted.If additional information is received a supplemental medwatch report will be submitted.
 
Manufacturer Narrative
A review of the device labeling was completed.Uveitis is identified in the labeling as a known adverse event following icl implantation.The dfu adequately provides instructions for icl implantation and includes a precaution: the lens should not be exposed to any solutions other than the normally used intraocular irrigating solutions (e.G.Isotonic saline, bss, viscoelastic, etc.).The dfu provides a caution: staar surgical evo/evo+icl and disposable accessories are packaged and sterilized for single use only.Cleaning, refurbishing, and/or resterilization are not applicable to these devices.If one of these devices were reused after cleaning, refurbishing, it is highly probable that it would be contaminated and the contamination could result in infection and/or inflammation.An exact cause could not be determined as the event could be multifactorial in nature including patient and/or procedure related factors, given the information that patient had pre-existing history of asthma and covid infection.Claim#: (b)(4).
 
Manufacturer Narrative
Originally this claim was determined to be reportable, but upon further review it was determined to not meet the definition of a complaint.New information indicated that there was no complaint against the implantable collamer lens.However, the claim cannot be voided as an mdr has already been submitted.The reported requested to cancel the claim, as there was no issue with the lens/eye.Claim# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC TORIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SUGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene muniz
1911 walker avenue
monrovia, CA 91016
6263037902
MDR Report Key18843051
MDR Text Key336959171
Report Number2023826-2024-00926
Device Sequence Number1
Product Code QCB
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
P030016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/05/2024
Initial Date FDA Received03/05/2024
Supplement Dates Manufacturer Received03/10/2024
Supplement Dates FDA Received05/24/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-